We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Pricing
Resources
Store
About us
Ask AI Chatbot Go to the Platform
en
中文 de es fr tr
Loading...
Store → Pharmaceutical Products → Pharmaceuticals, Medicinal Chemical And Botanical Products → Medicaments Containing Insulin But Not Antibiotics
Report Belgium - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update: Sep 1, 2023

Belgium - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?

Belgium: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Belgium

After two years of growth, the Belgian medicaments containing insulin market decreased by -95.3% to $X in 2021. Over the period under review, consumption recorded a sharp slump. Medicaments containing insulin consumption peaked at $X in 2014; however, from 2015 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Belgium

In value terms, medicaments containing insulin production amounted to $X in 2021 estimated in export price. Overall, production, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 with an increase of 30%. As a result, production attained the peak level of $X. From 2017 to 2021, production growth failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from Belgium

For the third consecutive year, Belgium recorded decline in overseas shipments of medicaments containing insulin but not antibiotics, which decreased by 0% to X tons in 2021. Overall, exports continue to indicate a significant increase. The pace of growth appeared the most rapid in 2015 when exports increased by 134%. The exports peaked in 2021 and are expected to retain growth in the near future.

In value terms, medicaments containing insulin exports amounted to $X in 2021. Over the period under review, exports recorded a significant expansion. The most prominent rate of growth was recorded in 2016 when exports increased by 286% against the previous year. The exports peaked in 2021 and are likely to see steady growth in the immediate term.

Exports by Country

The United States (X tons) was the main destination for medicaments containing insulin exports from Belgium, with a approx. 99.9% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to the United States totaled +1,238.2%.

From 2012 to 2021, the average annual growth rate of value to the United States amounted to +1,224.1%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, flattening at the previous year. Overall, the export price showed resilient growth. The most prominent rate of growth was recorded in 2019 an increase of 98% against the previous year. The export price peaked in 2021 and is likely to continue growth in the near future.

As there is only one major export destination, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for Zambia amounted to +60.6% per year.

Medicaments Containing Insulin Imports

Imports into Belgium

In 2021, overseas purchases of medicaments containing insulin but not antibiotics increased by 48% to X kg, rising for the fourth year in a row after three years of decline. Over the period under review, imports posted a significant increase. The pace of growth appeared the most rapid in 2013 with an increase of 33,867%. Imports peaked at X tons in 2014; however, from 2015 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports surged to $X in 2021. Overall, imports continue to indicate significant growth. The growth pace was the most rapid in 2013 when imports increased by 37,415%. As a result, imports attained the peak of $X. From 2014 to 2021, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2021, the Netherlands (X kg) was the main medicaments containing insulin supplier to Belgium, accounting for a approx. 100% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from the Netherlands amounted to +49.9%.

In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Belgium.

From 2012 to 2021, the average annual growth rate of value from the Netherlands amounted to +97.6%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, jumping by 27% against the previous year. Overall, the import price, however, saw a pronounced reduction. The growth pace was the most rapid in 2015 an increase of 106%. The import price peaked at $X per ton in 2017; however, from 2018 to 2021, import prices failed to regain momentum.

As there is only one major supplying country, the average price level is determined by prices for the Netherlands.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to +31.0% per year.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2022 2012-2022 2023-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, Denmark and Germany, together accounting for 72% of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in the world?
+
The United States constituted the country with the largest volume of medicaments containing insulin production, accounting for 67% of total volume. Moreover, medicaments containing insulin production in the United States exceeded the figures recorded by the second-largest producer, Germany, fivefold. India ranked third in terms of total production with a 5% share.
What are the leading suppliers of medicaments containing insulin but not antibiotics to Belgium?
+
In value terms, the Netherlands constituted the largest supplier of medicaments containing insulin but not antibiotics to Belgium.
What is the average export price for medicaments containing insulin but not antibiotics in Belgium?
+
The average medicaments containing insulin export price stood at $201,255 per ton in 2021, remaining constant against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in Belgium?
+
The average medicaments containing insulin import price stood at $179,738 per ton in 2021, surging by 27% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Belgium. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
• Belgium

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in Belgium
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

2.1
KEY FINDINGS
2.2
MARKET TRENDS  This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

This Chapter is Available Only for the Professional Edition PRO
4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

This Chapter is Available Only for the Professional Edition PRO
5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

This Chapter is Available Only for the Professional Edition PRO
6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2022
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2022
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
Table 1:
Key Findings In 2022
Table 2:
Market Volume, In Physical Terms, 2012–2022
Table 3:
Market Value, 2012–2022
Table 4:
Per Capita Consumption In 2012-2022
Table 5:
Imports, In Physical Terms, By Country, 2012–2022
Table 6:
Imports, In Value Terms, By Country, 2012–2022
Table 7:
Import Prices, By Country Of Origin, 2012–2022
Table 8:
Exports, In Physical Terms, By Country, 2012–2022
Table 9:
Exports, In Value Terms, By Country, 2012–2022
Table 10:
Export Prices, By Country Of Destination, 2012–2022
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2022
Figure 2:
Market Value, 2012–2022
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2022
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2022
Figure 5:
Trade Balance, In Physical Terms, 2012-2022
Figure 6:
Trade Balance, In Value Terms, 2012-2022
Figure 7:
Per Capita Consumption, 2012-2022
Figure 8:
Market Volume Forecast to 2030
Figure 9:
Market Value Forecast to 2030
Figure 10:
Products: Market Size And Growth, By Type
Figure 11:
Products: Average Per Capita Consumption, By Type
Figure 12:
Products: Exports And Growth, By Type
Figure 13:
Products: Export Prices And Growth, By Type
Figure 14:
Production Volume And Growth
Figure 15:
Exports And Growth
Figure 16:
Export Prices And Growth
Figure 17:
Market Size And Growth
Figure 18:
Per Capita Consumption
Figure 19:
Imports And Growth
Figure 20:
Import Prices
Figure 21:
Production, In Physical Terms, 2012–2022
Figure 22:
Production, In Value Terms, 2012–2022
Figure 23:
Imports, In Physical Terms, 2012–2022
Figure 24:
Imports, In Value Terms, 2012–2022
Figure 25:
Imports, In Physical Terms, By Country, 2022
Figure 26:
Imports, In Physical Terms, By Country, 2012–2022
Figure 27:
Imports, In Value Terms, By Country, 2012–2022
Figure 28:
Import Prices, By Country Of Origin, 2012–2022
Figure 29:
Exports, In Physical Terms, 2012–2022
Figure 30:
Exports, In Value Terms, 2012–2022
Figure 31:
Exports, In Physical Terms, By Country, 2022
Figure 32:
Exports, In Physical Terms, By Country, 2012–2022
Figure 33:
Exports, In Value Terms, By Country, 2012–2022
Figure 34:
Export Prices, By Country Of Destination, 2012–2022
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces
Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices
Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET

• • •
© 2023 IndexBox, Inc